top of page

Type 2 Diabetes and No-Exam Term Life Insurance: What Underwriters Usually Review

Written by: Jeff Schmidt | Licensed Insurance Broker | CarePro Insurance Content reviewed for accuracy. Not legal, tax, or financial advice.

Term life insurance for type 2 diabetes no exam is often possible, but pricing depends on control and history. Here's what carriers typically look at and how to shop smart.

  • Instant online pricing

  • No phone calls required

  • No pressure from agents

Type 2 Diabetes: What Matters Most

A1C trend and how treatment has changed over time

Medication type and whether complications are present

How to compare quotes using consistent assumptions

Type 2 diabetes doesn't automatically block you from no-exam term life. Most carriers care less about the label and more about how well it's controlled. The primary measurement tool underwriters rely on is A1C - a lab value that measures the average percentage of sugar attached to hemoglobin over roughly three months, giving a rolling picture of blood sugar control rather than a snapshot of a single day. Because it captures a 90-day average, A1C is harder to temporarily influence than a fasting glucose reading taken once in a clinical setting, which is why carriers use it as the centerpiece of their diabetes review.

Expect questions about recent A1C results, medications, and whether you've had any diabetes-related complications. Stability over time is usually a positive signal. An A1C trending downward - for example, moving from 8.5 to 7.2 over a two-year period - signals improving control and reflects effort that has produced measurable results, which underwriters typically view more favorably than a number that is flat or rising. Carriers often look at multiple A1C data points over time rather than a single reading, so a record that shows consistent improvement or sustained stability across two or three years is more useful than any one lab value taken in isolation. Bringing documentation of that trend, not just the most recent result, puts the underwriting review on firmer ground.

If you've had recent medication changes or new findings, you may see more follow-up. That doesn't mean it's a no - it just means the carrier wants a clearer picture. Complication history is reviewed in specific categories: kidney involvement (nephropathy, where the kidneys filter blood less efficiently), nerve damage (neuropathy, which may present as tingling, numbness, or pain in the extremities), eye changes (retinopathy, involving blood vessel changes in the retina), and cardiovascular complications affecting the heart. Each category is evaluated separately, and the presence or absence of complications often matters more to the underwriter than the A1C number alone - a person with a slightly elevated A1C and no complications may be rated more favorably than someone with a lower A1C who has documented kidney involvement. Having the name, dosage, and start date for each diabetes-related medication - including any that were tried and discontinued - gives the underwriter the factual sequence they need without having to chase additional records.

When comparing quotes, make sure the assumptions match your situation. A quote built on "diet-controlled" looks different than one built on multiple meds or insulin. Carriers also differ in how they treat oral medication versus injectable non-insulin therapy versus insulin, and some draw a more definitive line at insulin than others do. Structuring every quote around your actual current treatment plan - including the specific medications and doses you take - is the only way to get a comparison that will hold up through underwriting. A quote built on a more favorable assumption than your actual situation creates a gap that will surface later and change the numbers.

The best prep is simple: know your last couple A1C readings, your meds, and your follow-up schedule. Accurate inputs lead to quotes that are closer to the final offer. Having the specific dates and values of your two or three most recent A1C tests is more useful than a general summary, because carriers want to see whether the trend is improving, stable, or moving in the wrong direction. If your doctor runs labs annually, pulling those results before you apply gives you exactly the data points the underwriter will be evaluating. The more specific and complete your inputs, the fewer surprises occur after the initial quote. If your follow-up schedule includes a nephrologist, ophthalmologist, or other specialist, noting those relationships and the dates of most recent visits demonstrates active management that underwriters weigh positively alongside the lab values.

For the main instant term life guide and underwriting basics, visit: https://www.careproinsurance.com/instant-term-life-insurance

Disclaimer: General information only, not medical, legal, or tax advice. Quotes are estimates; final eligibility and rates depend on underwriting and carrier guidelines.

Frequently Asked Questions

Can I get no-exam term life insurance with type 2 diabetes?

Often, yes. Eligibility depends on factors like recent A1C results, treatment type, and whether there are complications. Some cases stay accelerated; others require additional review.

Does insulin automatically disqualify me from no-exam programs?

Not always, but it can change which programs are available and how the case is priced. Carriers may ask more questions and may request records depending on the overall picture.

What A1C level do carriers look for?

There isn't one universal cutoff. Carriers typically look at trends over time and overall control, along with treatment and any related conditions.

What diabetes complications matter for underwriting?

Complications can include kidney issues, neuropathy, eye findings, or cardiovascular history. The type and severity can affect both eligibility and pricing.

Why do quotes vary so much between carriers?

Carriers weigh diabetes details differently. Differences in definitions, risk tolerance, and program rules can lead to different rate classes even with similar information.

How far back do carriers look at A1C history?

Most carriers want to see at least two to three years of A1C history to assess trend direction, though some will look further back if records are available through a medical records request. The goal is to determine whether blood sugar control is improving, stable, or worsening over time - a single reading provides a data point, but a trend line tells the underwriter much more. If you were only recently diagnosed and have limited history, carriers typically work with what's available and may ask for additional documentation.

Does diet-controlled diabetes with no medication get treated differently?

Yes - diet-controlled type 2 diabetes, where A1C is within an acceptable range and no medication has been prescribed, is generally evaluated more favorably than cases involving oral medications or insulin. The absence of medication signals that blood sugar is being managed through lifestyle alone, which many carriers treat as a lower-complexity case. That said, A1C values and complication history still matter, so the overall picture needs to be clean for the most favorable underwriting outcome.

What if I was recently diagnosed and don't have a long A1C history yet?

A recent diagnosis with limited A1C history is a common scenario, and carriers typically handle it by working with the records available rather than automatically declining. If you have two or three readings over the past 6-12 months that show stable or improving values and no complications, that trajectory can support a favorable review even without years of history. Some carriers may ask for attending physician records to supplement what the databases show, which adds time to the process but doesn't automatically disadvantage your application.

bottom of page